A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
מצבים רפואיים
Systemic Lupus Erythematosus (With and Without Nephritis) · Idiopathic Inflammatory Myopathy · Systemic Sclerosis
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Mayo Clinic, Phoenix, Arizona, United States
Contact: Principal Investigator (Vivek Nagaraja, MD)Loma Linda University Medical Center, Loma Linda, California, United States
Contact: Principal Investigator (Hisham Abdel-Azim, MD)University of Colorado Denver, Aurora, Colorado, United States
Contact: Principal Investigator (Melissa Griffith, MD)Mayo Clinic, Jacksonville, Florida, United States
Contact: Principal Investigator (Vikas Majithia, MD)The University of Chicago Medical Center, Chicago, Illinois, United States
Contact: Principal Investigator (Michael Macklin, MD)University of Iowa, Iowa City, Iowa, United States
Contact: Principal Investigator (Hanna Zembrzuska, MD)Norton Cancer Institute, St. Matthews Campus, Louisville, Kentucky, United States
Contact: Principal Investigator (Don Stevens, MD)Astera Cancer Care, East Brunswick, New Jersey, United States
Contact: Principal Investigator (Birju Bhatt, MD)Icahn School of Medicine at Mount Sinai, New York, New York, United States
Contact: Principal Investigator (Margrit Wiesendanger, MD)Duke University Medical Center, Durham, North Carolina, United States
Contact: Principal Investigator (Lisa Criscione-Schreiber, MD)Medical University of South Carolina, Charleston, South Carolina, United States
Contact: Principal Investigator (Melissa Cunningham, MD)Prisma Health, Greenville, South Carolina, United States
Contact: Principal Investigator (Cory McGee, MD)LDS Hospital - lntermountain Health, Salt Lake City, Utah, United States
Contact: Principal Investigator (Pankhuri Gupta, MD)Hôpital Maisonneuve Rosemont, Montreal, Quebec, Canada
Contact: Principal Investigator (Nicolas Richard, MD)
מובילי המחקר
Allogene Study Director
Study Director
Allogene Therapeutics, Inc.